Patel Samir Rashmikant
- SEC CIK
- 0001702447
No open-market purchases or sales filed in the past year.
Current role at each company
- AKTX Akari Therapeutics PlcDirector, 10% Owneras of Jul 17, 2026
- CYDY CytoDyn Inc.Directoras of Nov 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Patel Samir Rashmikant as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKTX Akari Therapeutics Plc
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Patel Samir RashmikantDirector, 10% Owner | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +1.24M | $0.4041 | +$250.0K | –618.7K after | Derivative2 lots |
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Patel Samir RashmikantDirector, 10% Owner | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +464.0K | $0.4041 | +$93.7K | –232.0K after | Derivative2 lots |